2024 Q2 Form 10-Q Financial Statement

#000134176624000029 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $402.0M $355.7M $259.9M
YoY Change 23.35% 36.84% 94.87%
Cost Of Revenue $192.9M $173.5M $146.1M
YoY Change 15.57% 18.74% 83.81%
Gross Profit $209.1M $182.2M $113.8M
YoY Change 31.51% 60.09% 111.19%
Gross Profit Margin 52.02% 51.22% 43.79%
Selling, General & Admin $113.4M $97.62M $68.91M
YoY Change 20.35% 41.67% 57.4%
% of Gross Profit 54.21% 53.57% 60.54%
Research & Development $200.0K $200.0K $300.0K
YoY Change 0.0% -33.33% 200.0%
% of Gross Profit 0.1% 0.11% 0.26%
Depreciation & Amortization $1.200M $1.229M $400.0K
YoY Change 100.0% 207.25% 100.0%
% of Gross Profit 0.57% 0.67% 0.35%
Operating Expenses $200.0K $200.0K $300.0K
YoY Change 0.0% -33.33% -99.31%
Operating Profit $94.25M $83.19M $44.91M
YoY Change 45.42% 85.22% 343.98%
Interest Expense $10.38M $9.271M $4.851M
YoY Change 123.68% 91.12% 242450.0%
% of Operating Profit 11.02% 11.14% 10.8%
Other Income/Expense, Net $10.38M $9.271M $4.851M
YoY Change 123.68% 91.12% -5740.7%
Pretax Income $104.6M $92.46M $49.76M
YoY Change 50.65% 85.8% 396.15%
Income Tax $24.85M $14.65M $8.537M
% Of Pretax Income 23.75% 15.84% 17.15%
Net Earnings $79.78M $77.81M $41.23M
YoY Change 54.89% 88.74% 515.33%
Net Earnings / Revenue 19.85% 21.87% 15.86%
Basic Earnings Per Share $0.29 $0.28 $0.41
Diluted Earnings Per Share $0.28 $0.27 $0.40
COMMON SHARES
Basic Shares Outstanding 233.1M shares 232.8M shares 76.71M
Diluted Shares Outstanding 237.6M shares 237.5M shares 78.76M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $903.2M $879.5M $595.5M
YoY Change 32.62% 47.7% 2232.27%
Cash & Equivalents $903.2M $879.5M $595.5M
Short-Term Investments
Other Short-Term Assets $37.02M $35.65M $67.74M
YoY Change -1.33% -47.37% 574.53%
Inventory $180.7M $197.5M $154.3M
Prepaid Expenses
Receivables $262.9M $200.1M $172.0M
Other Receivables $1.166M $2.259M $3.587M
Total Short-Term Assets $1.385B $1.315B $993.1M
YoY Change 29.17% 32.41% 233.03%
LONG-TERM ASSETS
Property, Plant & Equipment $36.28M $28.35M $12.05M
YoY Change 128.3% 135.19% 225.61%
Goodwill $13.73M $13.87M $13.95M
YoY Change -1.49% -0.6% -2.03%
Intangibles $11.49M $11.74M $12.36M
YoY Change -5.9% -5.0% -21.97%
Long-Term Investments $6.653M $7.963M $263.0K
YoY Change 2519.29% 2927.76% -10.24%
Other Assets $6.653M $267.2M $259.4M
YoY Change -97.66% 3.02% 3955.86%
Total Long-Term Assets $333.9M $331.1M $299.2M
YoY Change 2.11% 10.68% 554.39%
TOTAL ASSETS
Total Short-Term Assets $1.385B $1.315B $993.1M
Total Long-Term Assets $333.9M $331.1M $299.2M
Total Assets $1.719B $1.646B $1.292B
YoY Change 22.84% 27.38% 275.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.40M $40.20M $16.54M
YoY Change -24.52% 143.11% -67.28%
Accrued Expenses $79.63M $63.87M $36.44M
YoY Change 152.69% 75.26% 185.4%
Deferred Revenue $9.513M $9.600M
YoY Change 0.14%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $61.00K $61.00K $69.00K
YoY Change -8.96% -11.59% -51.06%
Total Short-Term Liabilities $313.0M $315.3M $191.7M
YoY Change 16.25% 64.43% 71.57%
LONG-TERM LIABILITIES
Long-Term Debt $228.0K $245.0K $156.0K
YoY Change 55.1% 57.05% 13.04%
Other Long-Term Liabilities $163.2M $990.2M $175.6M
YoY Change -5.09% 463.85% 29315.58%
Total Long-Term Liabilities $163.5M $990.4M $175.8M
YoY Change -5.04% 463.49% 23813.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $313.0M $315.3M $191.7M
Total Long-Term Liabilities $163.5M $990.4M $175.8M
Total Liabilities $478.6M $483.5M $386.7M
YoY Change 7.88% 25.01% 234.64%
SHAREHOLDERS EQUITY
Retained Earnings $131.9M $58.92M -$197.6M
YoY Change -190.25% -129.81% 341.13%
Common Stock $78.00K $78.00K $77.00K
YoY Change 1.3% 1.3% 2.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $415.8M $338.2M $81.04M
YoY Change
Total Liabilities & Shareholders Equity $1.719B $1.646B $1.292B
YoY Change 22.84% 27.38% 275.74%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $79.78M $77.81M $41.23M
YoY Change 54.89% 88.74% 515.33%
Depreciation, Depletion And Amortization $1.200M $1.229M $400.0K
YoY Change 100.0% 207.25% 100.0%
Cash From Operating Activities $39.64M $134.6M -$13.83M
YoY Change -32.86% -1073.53% -251.99%
INVESTING ACTIVITIES
Capital Expenditures $9.214M $4.525M $2.253M
YoY Change 102.19% 100.84% 203.64%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $3.233M
YoY Change -100.0%
Cash From Investing Activities -$9.214M -$4.525M $980.0K
YoY Change 102.19% -561.73% -232.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.673M -$5.885M -6.314M
YoY Change 0.53% -6.79% -899.24%
NET CHANGE
Cash From Operating Activities 39.64M $134.6M -13.83M
Cash From Investing Activities -9.214M -$4.525M 980.0K
Cash From Financing Activities -6.673M -$5.885M -6.314M
Net Change In Cash 23.76M $123.5M -19.35M
YoY Change -50.35% -738.46% -308.54%
FREE CASH FLOW
Cash From Operating Activities $39.64M $134.6M -$13.83M
Capital Expenditures $9.214M $4.525M $2.253M
Free Cash Flow $30.43M $130.1M -$16.08M
YoY Change -44.15% -909.03% -292.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21523000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19503000 usd
CY2024Q1 celh Deferred Contract Costs Current
DeferredContractCostsCurrent
14124000 usd
CY2023Q4 celh Deferred Contract Costs Current
DeferredContractCostsCurrent
14124000 usd
CY2024Q1 us-gaap Deposits Assets
DepositsAssets
7963000 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
291000 usd
CY2024Q1 celh Deferred Other Costs Non Current
DeferredOtherCostsNonCurrent
244807000 usd
CY2023Q4 celh Deferred Other Costs Non Current
DeferredOtherCostsNonCurrent
248338000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11741000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12139000 usd
CY2024Q1 us-gaap Goodwill
Goodwill
13866000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
14173000 usd
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9513000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9513000 usd
CY2024Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
164849000 usd
CY2023Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
167227000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
173501000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
146121000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
182207000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
113818000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99017000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68905000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
83190000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
44913000 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
45000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9612000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4924000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-369000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-118000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9271000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4851000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
92461000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49764000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14650000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8537000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
77811000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
41227000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6837000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6781000 usd
CY2024Q1 celh Earnings Loss Allocated To Participating Shares
EarningsLossAllocatedToParticipatingShares
6128000 usd
CY2023Q1 celh Earnings Loss Allocated To Participating Shares
EarningsLossAllocatedToParticipatingShares
2934000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64846000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
31512000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1354000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
594000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
63492000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32106000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232780000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230019000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237523000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
236277000 shares
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
3
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
264040000 usd
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1467000 shares
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
824488000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3563000 usd
CY2024Q1 celh Issuance Of Common Stock Pursuant To Exercise Of Stock Options Cashless
IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashless
968000 usd
CY2024Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
6837000 usd
CY2024Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1354000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
77811000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
338191000 usd
CY2024Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1467000 shares
CY2024Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
824488000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
40091000 usd
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1467000 shares
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
824488000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5507000 usd
CY2023Q1 celh Issuance Of Common Stock Pursuant To Exercise Of Stock Options Cashless
IssuanceOfCommonStockPursuantToExerciseOfStockOptionsCashless
479000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
6781000 usd
CY2023Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
594000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
41227000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
81035000 usd
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1467000 shares
CY2023Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
824488000 usd
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
3
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
77811000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
41227000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1229000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
549000 usd
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2250000 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
837000 usd
CY2024Q1 celh Amortization Of Deferred Other Costs
AmortizationOfDeferredOtherCosts
3531000 usd
CY2023Q1 celh Amortization Of Deferred Other Costs
AmortizationOfDeferredOtherCosts
3531000 usd
CY2024Q1 celh Inventory Allowance For Excess And Obsolete Products
InventoryAllowanceForExcessAndObsoleteProducts
-2386000 usd
CY2023Q1 celh Inventory Allowance For Excess And Obsolete Products
InventoryAllowanceForExcessAndObsoleteProducts
-1672000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3563000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5507000 usd
CY2024Q1 celh Deferred Tax Liabilitynet
DeferredTaxLiabilitynet
6450000 usd
CY2023Q1 celh Deferred Tax Liabilitynet
DeferredTaxLiabilitynet
2873000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-369000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-69000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18664000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
109639000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-29386000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17338000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2076000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4166000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3013000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-19712000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1998000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12643000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8250000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7251000 usd
CY2024Q1 celh Increase Decrease In Accrued Promotional Allowance
IncreaseDecreaseInAccruedPromotionalAllowance
29414000 usd
CY2023Q1 celh Increase Decrease In Accrued Promotional Allowance
IncreaseDecreaseInAccruedPromotionalAllowance
32248000 usd
CY2024Q1 celh Increase Decrease In Accrued Distributor Terminations Fees
IncreaseDecreaseInAccruedDistributorTerminationsFees
-248000 usd
CY2023Q1 celh Increase Decrease In Accrued Distributor Terminations Fees
IncreaseDecreaseInAccruedDistributorTerminationsFees
-2923000 usd
CY2024Q1 celh Increase Decrease In Deferred Revenue And Other Current Liabilities
IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities
2094000 usd
CY2023Q1 celh Increase Decrease In Deferred Revenue And Other Current Liabilities
IncreaseDecreaseInDeferredRevenueAndOtherCurrentLiabilities
1508000 usd
CY2024Q1 celh Change In Right To Use And Lease Obligationnet
ChangeInRightToUseAndLeaseObligationnet
-23000 usd
CY2023Q1 celh Change In Right To Use And Lease Obligationnet
ChangeInRightToUseAndLeaseObligationnet
-15000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2378000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4625000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
7672000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
4000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
134649000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13831000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
3233000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4525000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2253000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4525000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
980000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
15000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
11000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
967000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
478000 usd
CY2024Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6837000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6781000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5885000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6314000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-722000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-181000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
123517000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-19346000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
755981000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
652927000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
879498000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
633581000 usd
CY2024Q1 us-gaap Taxes Other
TaxesOther
320000 usd
CY2023Q1 us-gaap Taxes Other
TaxesOther
408000 usd
CY2023Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
3
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Significant Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> — The preparation of consolidated financial statements and accompanying disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from those estimates. Significant estimates include promotional allowance, the allowance for current expected credit losses, allowance for inventory obsolescence and sales returns, the useful lives of property and equipment, impairment of goodwill and intangibles, deferred taxes and related valuation allowance, and the valuation of stock-based compensation.</span></div>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Concentrations of Risk </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">— Substantially all of the Company’s revenue is derived from the sale of Celsius® functional energy drinks and liquid supplements.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue from customers accounting for more than 10% of total revenue for the three months ended March 31, 2024 and 2023 was as follows:</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.363%"><tr><td style="width:1.0%"></td><td style="width:71.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.107%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.428%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For The Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pepsi</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Costco</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30.6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">100.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">100.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable —</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> As of March 31, 2024 and December 31, 2023, Pepsi was the only customer with a balance greater than 10% of total accounts receivable as of the end of such periods. The accounts receivable balance due from Pepsi represented 67.9% and 69.0% of total accounts receivable as of March 31, 2024 and December 31, 2023, respectively.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily include cash and cash equivalents, accounts receivable and a note receivable. The Company ensures that its cash and cash equivalents are held with reputable financial institutions to mitigate this risk. At times, balances in the Company’s cash accounts may exceed the Federal Deposit Insurance Corporation ("FDIC") limit. As of March 31, 2024 and December 31, 2023, the Company had approximately $879.0 million and $755.5 million, respectively, in excess of the FDIC limit.</span></div>
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
879000000 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
755500000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3137000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2215000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5352000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4200000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4200000 usd
CY2024Q1 celh Longlived Assets Related To Foreign Operations
LonglivedAssetsRelatedToForeignOperations
14047000 usd
CY2023Q4 celh Longlived Assets Related To Foreign Operations
LonglivedAssetsRelatedToForeignOperations
14394000 usd
CY2024Q1 celh Total Longlived Assets
TotalLonglivedAssets
41590000 usd
CY2023Q4 celh Total Longlived Assets
TotalLonglivedAssets
38710000 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
46500000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
31000000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
300000 usd
CY2024Q1 celh Exchange Losses
ExchangeLosses
400000 usd
CY2023Q1 celh Exchange Losses
ExchangeLosses
100000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
1400000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
600000 usd
CY2024Q1 celh Freight Expense
FreightExpense
14000000 usd
CY2023Q1 celh Freight Expense
FreightExpense
14200000 usd
CY2024Q1 celh State Beverage Container Deposit
StateBeverageContainerDeposit
10900000 usd
CY2023Q4 celh State Beverage Container Deposit
StateBeverageContainerDeposit
10100000 usd
CY2024Q1 celh Value Added Tax Payment
ValueAddedTaxPayment
2100000 usd
CY2023Q4 celh Value Added Tax Payment
ValueAddedTaxPayment
800000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
77811000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
41227000 usd
CY2024Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6837000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6781000 usd
CY2024Q1 us-gaap Undistributed Earnings
UndistributedEarnings
-6128000 usd
CY2023Q1 us-gaap Undistributed Earnings
UndistributedEarnings
-2934000 usd
CY2024Q1 celh Net Income Attributable To Common Shareholders
NetIncomeAttributableToCommonShareholders
64846000 usd
CY2023Q1 celh Net Income Attributable To Common Shareholders
NetIncomeAttributableToCommonShareholders
31512000 usd
CY2024Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
6128000 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
2934000 usd
CY2024Q1 celh Undistributed Earnings Loss Re Allocated To Participating Securities Diluted
UndistributedEarningsLossReAllocatedToParticipatingSecuritiesDiluted
6016000 usd
CY2023Q1 celh Undistributed Earnings Loss Re Allocated To Participating Securities Diluted
UndistributedEarningsLossReAllocatedToParticipatingSecuritiesDiluted
2941000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
64958000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
31505000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
232780000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230019000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4743000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6258000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
237523000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
236277000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q1 celh Potentially Dilutive Shares Outstanding
PotentiallyDilutiveSharesOutstanding
22000000 shares
CY2024Q1 celh Potentially Dilutive Shares Outstanding
PotentiallyDilutiveSharesOutstanding
22000000 shares
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
355708000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
259939000 usd
CY2024Q1 celh Promotional Allowance
PromotionalAllowance
95000000 usd
CY2023Q1 celh Promotional Allowance
PromotionalAllowance
65500000 usd
CY2024Q1 celh Accrued Promotional Allowance
AccruedPromotionalAllowance
129200000 usd
CY2023Q4 celh Accrued Promotional Allowance
AccruedPromotionalAllowance
99800000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
169088000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
184434000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
32632000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
49022000 usd
CY2024Q1 celh Less Inventory Allowance For Excess And Obsolete Products
LessInventoryAllowanceForExcessAndObsoleteProducts
4216000 usd
CY2023Q4 celh Less Inventory Allowance For Excess And Obsolete Products
LessInventoryAllowanceForExcessAndObsoleteProducts
4181000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
197504000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
229275000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21500000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19500000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
3412000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
3471000 usd
CY2024Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1153000 usd
CY2023Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
1153000 usd
CY2024Q1 us-gaap Notes Receivable Net
NotesReceivableNet
2259000 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
2318000 usd
CY2024Q1 us-gaap Long Term Debt Term
LongTermDebtTerm
P5Y
CY2024Q1 celh Instalment Collateral Shares
InstalmentCollateralShares
60000 shares
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5625000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4650000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28350000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24868000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
1100000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
400000 usd
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
13900000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
14200000 usd
CY2024Q1 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
13600000 usd
CY2023Q4 us-gaap Finite Lived Customer Relationships Gross
FiniteLivedCustomerRelationshipsGross
13902000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2312000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2233000 usd
CY2024Q1 celh Finite Lived Intangible Assets Effect Of Exchange Rate
FiniteLivedIntangibleAssetsEffectOfExchangeRate
1000 usd
CY2023Q4 celh Finite Lived Intangible Assets Effect Of Exchange Rate
FiniteLivedIntangibleAssetsEffectOfExchangeRate
9000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11289000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11678000 usd
CY2024Q1 celh Brands Total Carrying Amount
BrandsTotalCarryingAmount
461000 usd
CY2023Q4 celh Brands Total Carrying Amount
BrandsTotalCarryingAmount
446000 usd
CY2024Q1 celh Intangible Assets Effect Of Exchange Rate Changes Gain Loss
IntangibleAssetsEffectOfExchangeRateChangesGainLoss
-9000 usd
CY2023Q4 celh Intangible Assets Effect Of Exchange Rate Changes Gain Loss
IntangibleAssetsEffectOfExchangeRateChangesGainLoss
15000 usd
CY2024Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
452000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
461000 usd
CY2024Q1 celh Total Intangibles
TotalIntangibles
11741000 usd
CY2023Q4 celh Total Intangibles
TotalIntangibles
12139000 usd
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P25Y
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
408000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
544000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
544000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
544000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
544000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8705000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11289000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
40200000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
42800000 usd
CY2024Q1 celh Freight
Freight
2317000 usd
CY2023Q4 celh Freight
Freight
2267000 usd
CY2024Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
17781000 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
18252000 usd
CY2024Q1 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
3767000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
7633000 usd
CY2024Q1 celh Unbilled Purchases
UnbilledPurchases
15142000 usd
CY2023Q4 celh Unbilled Purchases
UnbilledPurchases
11851000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24864000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
22117000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
63871000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
62120000 usd
CY2024Q1 celh Contract With Customer Liability Revenue Recognition Term
ContractWithCustomerLiabilityRevenueRecognitionTerm
P20Y
CY2024Q1 celh Contract With Customer Liability Revenue Recognition Term
ContractWithCustomerLiabilityRevenueRecognitionTerm
P20Y
CY2024Q1 celh Percentage Of Voting Right Preferred Stock
PercentageOfVotingRightPreferredStock
0.50
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.158
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.172
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4918000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.81
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
249541000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M12D
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
767000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.26
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
48750000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4151000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.28
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
326444000 usd
CY2024Q1 celh Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Terms2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms2
P4Y9M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4151000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.28
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
326444000 usd
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
23000000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
700000 shares
CY2023Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
82600000 usd
CY2023Q1 celh Reducing Award Damages Value
ReducingAwardDamagesValue
2100000 usd
CY2023Q1 celh Post Judgment Interest
PostJudgmentInterest
0.0552
CY2024Q1 celh Contingent Commitment To Third Parties
ContingentCommitmentToThirdParties
73000000 usd
CY2023Q4 celh Contingent Commitment To Third Parties
ContingentCommitmentToThirdParties
55300000 usd
CY2024Q1 us-gaap Contractual Obligation
ContractualObligation
42500000 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
34400000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001341766-24-000029-index-headers.html Edgar Link pending
0001341766-24-000029-index.html Edgar Link pending
0001341766-24-000029.txt Edgar Link pending
0001341766-24-000029-xbrl.zip Edgar Link pending
celh-20240331.htm Edgar Link pending
celh-20240331.xsd Edgar Link pending
celh-20240331xexx311.htm Edgar Link pending
celh-20240331xexx312.htm Edgar Link pending
celh-20240331xexx321.htm Edgar Link pending
celh-20240331xexx322.htm Edgar Link pending
celh-20240331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
paulstorey.htm Edgar Link pending
paulstorey001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
celh-20240331_def.xml Edgar Link unprocessable
celh-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
celh-20240331_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tobydavid.htm Edgar Link pending
tobydavid001.jpg Edgar Link pending
tonyguilfoyle-amendment.htm Edgar Link pending
tonyguilfoyle-amendment001.jpg Edgar Link pending
tonyguilfoyle.htm Edgar Link pending
tonyguilfoyle001.jpg Edgar Link pending
celh-20240331_cal.xml Edgar Link unprocessable
celh-20240331_lab.xml Edgar Link unprocessable